Skip to main content

Anti-PD1 in combination with an inhibitor of PCSK9 to increase MHC class I molecule expression on tumor cells as immunotherapy for NSCLC

Research Grant
Duke Scholars

Administered By

Dermatology

Awarded By

Department of Defense

Start Date

June 15, 2021

End Date

June 14, 2024
 

Administered By

Dermatology

Awarded By

Department of Defense

Start Date

June 15, 2021

End Date

June 14, 2024